UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013718
Receipt number R000015940
Scientific Title Clinical evaluation research of GC Implant Aadva
Date of disclosure of the study information 2014/04/15
Last modified on 2022/05/09 17:22:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical evaluation research of GC Implant Aadva

Acronym

Clinical evaluation research of GC Implant Aadva

Scientific Title

Clinical evaluation research of GC Implant Aadva

Scientific Title:Acronym

Clinical evaluation research of GC Implant Aadva

Region

Japan


Condition

Condition

single or continuous two teeth loss

Classification by specialty

Dental medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A study to evaluate the 3 years clinical result of GC Implant Aadva in single or continuous two teeth loss

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

amount of marginal bone loss after implant loading

Key secondary outcomes

Evaluation of implant success/survival
Shaking of implant and pain
Rubor of peri implant tissue
Pus discharge
Exposure of implant
Oral hygiene


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

A study to evaluate the 3 years clinical result of GC Implant Aadva in single or continuous two teeth loss

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Subjects whom state of loss corresponds to either of condition in the following
Subjects with single or continuous two teeth loss
Subjects with 3 unit teeth loss from second primolar to second molar and no dental antagonist at second molar positon
2.Subjects with excellent general status.
3.Subjects with natural or restored medial and distal adjacent teeth to the missing tooth. The condition of the adjacent teeth will not change during this study.
4.Subjects with following bite condition
Subjects with A and B1 in Eichner classification
Subjects with B2 in Eichner classification and with support zone on the both side
5.Subjects who has dental antagonist irrespective of natural tooth, implant and denture.
6.Subjects with O Leary s Plaque Control score of <20% at screening.
7.Subjects with sufficient bone mass(Bone width 6mm or more of the platform position, Bone height 10mm or more(in lower jow the distance between the mandibular canal)) in the implant placement site.
8.Subjects who sign consent forms to show their agreement to take part in the study
9.Subjects (male and female) aged 20 years or older.

Key exclusion criteria

1.Subjects with a systemic disease that may affect the implant treatment, diabetes for example
2.Subjects with any of the diseases that is contraindicated or relatively contraindicated in oral surgical treatment disorders
3.Subjects with tooth root at planned implantation
4. Subjects with bone graft to the extraction socket
5. Subjects with an untreated tooth that needs endodontic care in an adjacent part of the implant placement site
6. Subjects with a 4-mm or deeper periodontal pocket in an adjacent tooth of the implant placement site
7. Subjects with un-control of periodontal disease
8. Subjects with severe habits of bruxism or clenching
9. Subjects with extremely short intermaxillary distance or notable trismus due to temporomandibular joint dysfunction
10. Subjects with extreme occlusion failure
11. Subjects who smoke more than 10 cigarettes a day or subjects who cannot stop smoking for 2 weeks before and after the implant placement surgery
12. Subjects who plan to participate in other clinical trial, or investigation 30 days prior to or during this study
13. Subjects who are pregnant or nursing or subjects who plan to be pregnant during this study
14. Subjects who cannot understand this study or subjects that the investigator deems ineligible to participate in this study
15. Subjects who can not be mutual understanding or mental illness
16. Uncooperative subjects to treatment
17. Subjects who need sinus lift
18. Subjects with a history of failure of implant placement in the site where an implant is planned to be placed in this study
19. Subjects within 12 weeks of tooth extraction

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kiyoshi Koyano

Organization

Kyushu University Faculty of Dental Science

Division name

Implant and Rehabilitative Dentistry

Zip code


Address

3-1-1 Maidashi Higashi-ku Fukuoka 812-8582, Japan

TEL

092-642-6376

Email

koyano@dent.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoichiro Ogino

Organization

Kyushu University Faculty of Dental Science

Division name

Implant and Rehabilitative Dentistry

Zip code


Address

3-1-1 Maidashi Higashi-ku Fukuoka 812-8582, Japan

TEL

092-642-6441

Homepage URL


Email

ogino@dent.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu University Faculty of Dental Science
Implant and Rehabilitative Dentistry

Institute

Department

Personal name



Funding Source

Organization

GC Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 19 Day

Date of IRB

2014 Year 07 Month 30 Day

Anticipated trial start date

2013 Year 12 Month 25 Day

Last follow-up date

2019 Year 03 Month 11 Day

Date of closure to data entry

2019 Year 03 Month 11 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 04 Month 15 Day

Last modified on

2022 Year 05 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015940


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name